Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Visual impairment in aging and cognitive decline: experience in a Memory Clinic.

Marquié M, Castilla-Martí M, Valero S, Martínez J, Sánchez D, Hernández I, Rosende-Roca M, Vargas L, Mauleón A, Rodríguez-Gómez O, Abdelnour C, Gil S, Santos-Santos MA, Alegret M, Espinosa A, Ortega G, Pérez-Cordón A, Sanabria Á, Roberto N, Moreno-Grau S, de Rojas I, Simó R, Ciudin A, Hernández C, Orellana A, Monté-Rubio G, Benaque A, Ruiz A, Tárraga L, Boada M.

Sci Rep. 2019 Jun 18;9(1):8698. doi: 10.1038/s41598-019-45055-9.

2.

Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.

Dietlin S, Soto M, Kiyasova V, Pueyo M, de Mauleon A, Delrieu J, Ousset PJ, Vellas B.

J Alzheimers Dis. 2019;70(1):25-34. doi: 10.3233/JAD-190025.

PMID:
31127783
3.

Potentially modifiable factors associated with agitation and aggression in Alzheimer's disease: results of the ICTUS study.

de Mauleon A, Soto M, Ousset PJ, Nourhashemi F, Lepage B, Vellas B.

Int Psychogeriatr. 2019 Feb 4:1-8. doi: 10.1017/S1041610218001990. [Epub ahead of print]

PMID:
30714541
4.

Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI).

de Rojas I, Romero J, Rodríguez-Gomez O, Pesini P, Sanabria A, Pérez-Cordon A, Abdelnour C, Hernández I, Rosende-Roca M, Mauleón A, Vargas L, Alegret M, Espinosa A, Ortega G, Gil S, Guitart M, Gailhajanet A, Santos-Santos MA, Moreno-Grau S, Sotolongo-Grau O, Ruiz S, Montrreal L, Martín E, Pelejà E, Lomeña F, Campos F, Vivas A, Gómez-Chiari M, Tejero MA, Giménez J, Pérez-Grijalba V, Marquié GM, Monté-Rubio G, Valero S, Orellana A, Tárraga L, Sarasa M, Ruiz A, Boada M; FACEHBI study.

Alzheimers Res Ther. 2018 Nov 29;10(1):119. doi: 10.1186/s13195-018-0444-1.

5.

Exploring Genetic Associations of Alzheimer's Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes.

Espinosa A, Hernández-Olasagarre B, Moreno-Grau S, Kleineidam L, Heilmann-Heimbach S, Hernández I, Wolfsgruber S, Wagner H, Rosende-Roca M, Mauleón A, Vargas L, Lafuente A, Rodríguez-Gómez O, Abdelnour C, Gil S, Marquié M, Santos-Santos MA, Sanabria Á, Ortega G, Monté-Rubio G, Pérez A, Ibarria M, Ruiz S, Kornhuber J, Peters O, Frölich L, Hüll M, Wiltfang J, Luck T, Riedel-Heller S, Montrreal L, Cañabate P, Moreno M, Preckler S, Aguilera N, de Rojas I, Orellana A, Alegret M, Valero S, Nöthen MM, Wagner M, Jessen F, Tárraga L, Boada M, Ramírez A, Ruiz A.

Front Aging Neurosci. 2018 Oct 30;10:340. doi: 10.3389/fnagi.2018.00340. eCollection 2018.

6.

Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer's disease.

Sánchez D, Castilla-Marti M, Rodríguez-Gómez O, Valero S, Piferrer A, Martínez G, Martínez J, Serra J, Moreno-Grau S, Hernández-Olasagarre B, De Rojas I, Hernández I, Abdelnour C, Rosende-Roca M, Vargas L, Mauleón A, Santos-Santos MA, Alegret M, Ortega G, Espinosa A, Pérez-Cordón A, Sanabria Á, Ciudin A, Simó R, Hernández C, Villaoslada P, Ruiz A, Tàrraga L, Boada M.

Sci Rep. 2018 Nov 5;8(1):16345. doi: 10.1038/s41598-018-34577-3.

7.

Telemedicine for the management of neuropsychiatric symptoms in long-term care facilities: the DETECT study, methods of a cluster randomised controlled trial to assess feasibility.

Piau A, Nourhashemi F, De Mauléon A, Tchalla A, Vautier C, Vellas B, Duboue M, Costa N, Rumeau P, Lepage B, Soto Martin M.

BMJ Open. 2018 Jun 12;8(6):e020982. doi: 10.1136/bmjopen-2017-020982.

8.

Genome-wide significant risk factors on chromosome 19 and the APOE locus.

Moreno-Grau S, Hernández I, Heilmann-Heimbach S, Ruiz S, Rosende-Roca M, Mauleón A, Vargas L, Rodríguez-Gómez O, Alegret M, Espinosa A, Ortega G, Aguilera N, Abdelnour C, Neuroimaging Initiative AD, Gil S, Maier W, Sotolongo-Grau O, Tárraga L, Ramirez A, López-Arrrieta J, Antúnez C, Serrano-Ríos M, Boada M, Ruiz A.

Oncotarget. 2018 May 15;9(37):24590-24600. doi: 10.18632/oncotarget.25083. eCollection 2018 May 15.

9.

The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in Subjective Cognitive Decline.

Sanabria A, Alegret M, Rodriguez-Gomez O, Valero S, Sotolongo-Grau O, Monté-Rubio G, Abdelnour C, Espinosa A, Ortega G, Perez-Cordon A, Gailhajanet A, Hernandez I, Rosende-Roca M, Vargas L, Mauleon A, Sanchez D, Martin E, Rentz DM, Lomeña F, Ruiz A, Tarraga L, Boada M; FACEHBI study group.

Sci Rep. 2018 Feb 28;8(1):3828. doi: 10.1038/s41598-018-21644-y.

10.

The Role of Verb Fluency in the Detection of Early Cognitive Impairment in Alzheimer's Disease.

Alegret M, Peretó M, Pérez A, Valero S, Espinosa A, Ortega G, Hernández I, Mauleón A, Rosende-Roca M, Vargas L, Rodríguez-Gómez O, Abdelnour C, Berthier ML, Bak TH, Ruíz A, Tárraga L, Boada M.

J Alzheimers Dis. 2018;62(2):611-619. doi: 10.3233/JAD-170826.

PMID:
29480180
11.

Costs of Care of Agitation Associated With Dementia in 8 European Countries: Results From the RightTimePlaceCare Study.

Costa N, Wübker A, De Mauléon A, Zwakhalen SMG, Challis D, Leino-Kilpi H, Hallberg IR, Stephan A, Zabalegui A, Saks K, Molinier L, Wimo A, Vellas B, Sauerland D, Binot I, Soto ME; RightTimePlaceCare consortium.

J Am Med Dir Assoc. 2018 Jan;19(1):95.e1-95.e10. doi: 10.1016/j.jamda.2017.10.013.

PMID:
29275939
12.

FACEHBI: A Prospective Study of Risk Factors, Biomarkers and Cognition in a Cohort of Individuals with Subjective Cognitive Decline. Study Rationale and Research Protocols.

Rodriguez-Gomez O, Sanabria A, Perez-Cordon A, Sanchez-Ruiz D, Abdelnour C, Valero S, Hernandez I, Rosende-Roca M, Mauleon A, Vargas L, Alegret M, Espinosa A, Ortega G, Guitart M, Gailhajanet A, Sotolongo-Grau O, Moreno-Grau S, Ruiz S, Tarragona M, Serra J, Martin E, Peleja E, Lomeña F, Campos F, Vivas A, Gomez-Chiari M, Tejero MA, Giménez J, Pesini P, Sarasa M, Martinez G, Ruiz A, Tarraga L, Boada M.

J Prev Alzheimers Dis. 2017;4(2):100-108. doi: 10.14283/jpad.2016.122.

PMID:
29186280
13.

The ROSAS Cohort: A Prospective, Longitudinal Study of Biomarkers for Alzheimer's Disease. Strategy, Methods and Initial Results.

de Mauléon A, Soto M, Kiyasova V, Delrieu J, Guignot I, Galtier S, Lilamand M, Cantet C, Lala F, Sastre N, Andrieu S, Pueyo M, Ousset PJ, Vellas B.

J Prev Alzheimers Dis. 2017;4(3):183-193. doi: 10.14283/jpad.2017.8.

PMID:
29182709
14.

Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results.

Moreno-Grau S, Rodríguez-Gómez O, Sanabria Á, Pérez-Cordón A, Sánchez-Ruiz D, Abdelnour C, Valero S, Hernández I, Rosende-Roca M, Mauleón A, Vargas L, Lafuente A, Gil S, Santos-Santos MÁ, Alegret M, Espinosa A, Ortega G, Guitart M, Gailhajanet A, de Rojas I, Sotolongo-Grau Ó, Ruiz S, Aguilera N, Papasey J, Martín E, Peleja E; Alzheimer's Disease Neuroimaging Initiative, Lomeña F, Campos F, Vivas A, Gómez-Chiari M, Tejero MÁ, Giménez J, Serrano-Ríos M, Orellana A, Tárraga L, Ruiz A, Boada M; FACEHBI study group.

Alzheimers Dement. 2018 May;14(5):634-643. doi: 10.1016/j.jalz.2017.10.005. Epub 2017 Nov 20.

15.

Social Representation of Dementia: An Analysis of 5,792 Consecutive Cases Evaluated in a Memory Clinic.

Cañabate P, Martínez G, Rosende-Roca M, Moreno M, Preckler S, Valero S, Sotolongo O, Hernández I, Alegret M, Ortega G, Espinosa A, Mauleón A, Vargas L, Rodríguez O, Abdelnour C, Sánchez D, Martín E, Ruiz A, Tárraga L, Boada M.

J Alzheimers Dis. 2017;58(4):1099-1108. doi: 10.3233/JAD-161119.

16.

Impact of Recruitment Methods in Subjective Cognitive Decline.

Abdelnour C, Rodríguez-Gómez O, Alegret M, Valero S, Moreno-Grau S, Sanabria Á, Hernández I, Rosende-Roca M, Vargas L, Mauleón A, Sánchez D, Espinosa A, Ortega G, Pérez-Cordón A, Diego S, Gailhajanet A, Guitart M, Sotolongo-Grau Ó, Ruiz A, Tárraga L, Boada M.

J Alzheimers Dis. 2017;57(2):625-632. doi: 10.3233/JAD-160915.

PMID:
28269773
17.

Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.

Lacour A, Espinosa A, Louwersheimer E, Heilmann S, Hernández I, Wolfsgruber S, Fernández V, Wagner H, Rosende-Roca M, Mauleón A, Moreno-Grau S, Vargas L, Pijnenburg YA, Koene T, Rodríguez-Gómez O, Ortega G, Ruiz S, Holstege H, Sotolongo-Grau O, Kornhuber J, Peters O, Frölich L, Hüll M, Rüther E, Wiltfang J, Scherer M, Riedel-Heller S, Alegret M, Nöthen MM, Scheltens P, Wagner M, Tárraga L, Jessen F, Boada M, Maier W, van der Flier WM, Becker T, Ramirez A, Ruiz A.

Mol Psychiatry. 2017 Jan;22(1):153-160. doi: 10.1038/mp.2016.18. Epub 2016 Mar 15.

18.

Concordance between Subjective and Objective Memory Impairment in Volunteer Subjects.

Alegret M, Rodríguez O, Espinosa A, Ortega G, Sanabria A, Valero S, Hernández I, Rosende-Roca M, Vargas L, Abdelnour C, Mauleón A, Gailhajanet A, Martín E, Tárraga L, Rentz DM, Amariglio RE, Ruíz A, Boada M.

J Alzheimers Dis. 2015;48(4):1109-17. doi: 10.3233/JAD-150594.

PMID:
26444795
19.

Validation of the Spanish Version of the Face Name Associative Memory Exam (S-FNAME) in Cognitively Normal Older Individuals.

Alegret M, Valero S, Ortega G, Espinosa A, Sanabria A, Hernández I, Rodríguez O, Rosende-Roca M, Mauleón A, Vargas L, Martín E, Ruíz A, Tárraga L, Amariglio RE, Rentz DM, Boada M.

Arch Clin Neuropsychol. 2015 Nov;30(7):712-20. doi: 10.1093/arclin/acv050. Epub 2015 Aug 18.

20.

PLD3 in non-familial Alzheimer's disease.

Heilmann S, Drichel D, Clarimon J, Fernández V, Lacour A, Wagner H, Thelen M, Hernández I, Fortea J, Alegret M, Blesa R, Mauleón A, Roca MR, Kornhuber J, Peters O, Heun R, Frölich L, Hüll M, Heneka MT, Rüther E, Riedel-Heller S, Scherer M, Wiltfang J, Jessen F, Becker T, Tárraga L, Boada M, Maier W, Lleó A, Ruiz A, Nöthen MM, Ramirez A.

Nature. 2015 Apr 2;520(7545):E3-5. doi: 10.1038/nature14039. No abstract available.

PMID:
25832411
21.

Evaluation of Candidate Genes Related to Neuronal Apoptosis in Late-Onset Alzheimer’s Disease.

Moreno-Grau S, Barneda B, Carriba P, Marín J, Sotolongo-Grau O, Hernández I, Rosende-Roca M, Mauleón A, Vargas L, Espinosa A, Alegret M, Rodriguez O, Ortega G, Fernández MV, López-Arrieta J, Tárraga L, Boada M, Antúnez C, López J, Ruiz A, Comella JX.

J Alzheimers Dis. 2015;45(2):621-9.

PMID:
25613099
22.

Erratum to "Exploratory analysis of seven Alzheimer's disease genes: disease progression" [Neurobiol. Aging 34 (2013) 1310.e1-1310.e7].

Ruiz A, Hernández I, Ronsende-Roca M, González-Pérez A, Rodriguez-Noriega E, Ramírez-Lorca R, Mauleón A, Moreno-Rey C, Boswell L, Tune L, Valero S, Alegret M, Gayán J, Becker JT, Real LM, Tárraga L, Ballard C, Terrin M, Sherman S, Payami H, López OL, Mintzer JE, Boada M.

Neurobiol Aging. 2014 Nov;35(11):2661. doi: 10.1016/j.neurobiolaging.2014.06.016. Epub 2014 Sep 17. No abstract available.

PMID:
28911722
23.

Associated factors with antipsychotic use in long-term institutional care in eight European countries: Results from the RightTimePlaceCare study.

de Mauleon A, Sourdet S, Renom-Guiteras A, Gillette-Guyonnet S, Leino-Kilpi H, Karlsson S, Bleijlevens M, Zabategui A, Saks K, Vellas B, Jolley D, Soto M; RightTimePlaceCare Consortium.

J Am Med Dir Assoc. 2014;15(11):812-8. doi: 10.1016/j.jamda.2014.06.015. Epub 2014 Aug 14.

PMID:
25129474
24.

Association of TMEM106B rs1990622 marker and frontotemporal dementia: evidence for a recessive effect and meta-analysis.

Hernández I, Rosende-Roca M, Alegret M, Mauleón A, Espinosa A, Vargas L, Sotolongo-Grau O, Tárraga L, Boada M, Ruiz A.

J Alzheimers Dis. 2015;43(1):325-34. doi: 10.3233/JAD-132432.

PMID:
25096617
25.

Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment.

Alegret M, Cuberas-Borrós G, Espinosa A, Valero S, Hernández I, Ruíz A, Becker JT, Rosende-Roca M, Mauleón A, Sotolongo O, Castell-Conesa J, Roca I, Tárraga L, Boada M.

J Alzheimers Dis. 2014;41(3):739-48. doi: 10.3233/JAD-132516.

26.

Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene.

Ruiz A, Heilmann S, Becker T, Hernández I, Wagner H, Thelen M, Mauleón A, Rosende-Roca M, Bellenguez C, Bis JC, Harold D, Gerrish A, Sims R, Sotolongo-Grau O, Espinosa A, Alegret M, Arrieta JL, Lacour A, Leber M, Becker J, Lafuente A, Ruiz S, Vargas L, Rodríguez O, Ortega G, Dominguez MA; IGAP, Mayeux R, Haines JL, Pericak-Vance MA, Farrer LA, Schellenberg GD, Chouraki V, Launer LJ, van Duijn C, Seshadri S, Antúnez C, Breteler MM, Serrano-Ríos M, Jessen F, Tárraga L, Nöthen MM, Maier W, Boada M, Ramírez A.

Transl Psychiatry. 2014 Feb 4;4:e358. doi: 10.1038/tp.2014.2.

27.

Identification of misdiagnosed fronto-temporal dementia using APOE genotype and phenotype-genotype correlation analyses.

Hernández I, Mauleón A, Rosense-Roca M, Alegret M, Vinyes G, Espinosa A, Sotolongo-Grau O, Becker JT, Valero S, Tarraga L, López OL, Ruiz A, Boada M.

Curr Alzheimer Res. 2014 Feb;11(2):182-91.

28.

Cut-off scores of a brief neuropsychological battery (NBACE) for Spanish individual adults older than 44 years old.

Alegret M, Espinosa A, Valero S, Vinyes-Junqué G, Ruiz A, Hernández I, Rosende-Roca M, Mauleón A, Becker JT, Tárraga L, Boada M.

PLoS One. 2013 Oct 16;8(10):e76436. doi: 10.1371/journal.pone.0076436. eCollection 2013. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/acefbfc7-8fb6-4505-a273-0fdb4e2bb580.

29.

ATP5H/KCTD2 locus is associated with Alzheimer's disease risk.

Boada M, Antúnez C, Ramírez-Lorca R, DeStefano AL, González-Pérez A, Gayán J, López-Arrieta J, Ikram MA, Hernández I, Marín J, Galán JJ, Bis JC, Mauleón A, Rosende-Roca M, Moreno-Rey C, Gudnasson V, Morón FJ, Velasco J, Carrasco JM, Alegret M, Espinosa A, Vinyes G, Lafuente A, Vargas L, Fitzpatrick AL; Alzheimer’s Disease Neuroimaging Initiative, Launer LJ, Sáez ME, Vázquez E, Becker JT, López OL, Serrano-Ríos M, Tárraga L, van Duijn CM, Real LM, Seshadri S, Ruiz A.

Mol Psychiatry. 2014 Jun;19(6):682-7. doi: 10.1038/mp.2013.86. Epub 2013 Jul 16.

30.

A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved.

Espinosa A, Alegret M, Valero S, Vinyes-Junqué G, Hernández I, Mauleón A, Rosende-Roca M, Ruiz A, López O, Tárraga L, Boada M.

J Alzheimers Dis. 2013;34(3):769-80. doi: 10.3233/JAD-122002. Erratum in: J Alzheimers Dis. 2015;43(1):335.

PMID:
23271318
31.

Difficulties in intraoperative care.

Mauléon AL, Ekman SL.

J Perioper Pract. 2012 Oct;22(10):334-7.

PMID:
23162997
32.

Exploratory analysis of seven Alzheimer's disease genes: disease progression.

Ruiz A, Hernández I, Ronsende-Roca M, González-Pérez A, Rodriguez-Noriega E, Ramírez-Lorca R, Mauleón A, Moreno-Rey C, Boswell L, Tune L, Valero S, Alegret M, Gayán J, Becker JT, Real LM, Tárraga L, Ballard C, Terrin M, Sherman S, Payami H, López OL, Mintzer JE, Boada M.

Neurobiol Aging. 2013 Apr;34(4):1310.e1-7. doi: 10.1016/j.neurobiolaging.2012.08.014. Epub 2012 Oct 1. Erratum in: Neurobiol Aging. 2014 Nov;35(11):2661.

33.

Molecular evaluation of human ubiquilin 2 gene PXX domain in familial frontotemporal dementia patients.

Hernández I, Espinosa A, Real LM, Galán JJ, Mauleón A, Roca MR, Tárraga L, Ruiz A, Boada M.

J Neurol. 2012 Nov;259(11):2488-90. doi: 10.1007/s00415-012-6568-5. Epub 2012 Jun 24. No abstract available.

PMID:
22729385
34.

"Is that my leg?" patients' experiences of being awake during regional anesthesia and surgery.

Karlsson AC, Ekebergh M, Mauléon AL, Almerud Österberg S.

J Perianesth Nurs. 2012 Jun;27(3):155-64. doi: 10.1016/j.jopan.2012.02.005.

PMID:
22612885
35.

A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.

Alegret M, Cuberas-Borrós G, Vinyes-Junqué G, Espinosa A, Valero S, Hernández I, Roca I, Ruíz A, Rosende-Roca M, Mauleón A, Becker JT, Castell-Conesa J, Tárraga L, Boada M.

J Alzheimers Dis. 2012;30(1):109-20. doi: 10.3233/JAD-2012-111850.

36.

The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease.

Antúnez C, Boada M, González-Pérez A, Gayán J, Ramírez-Lorca R, Marín J, Hernández I, Moreno-Rey C, Morón FJ, López-Arrieta J, Mauleón A, Rosende-Roca M, Noguera-Perea F, Legaz-García A, Vivancos-Moreau L, Velasco J, Carrasco JM, Alegret M, Antequera-Torres M, Manzanares S, Romo A, Blanca I, Ruiz S, Espinosa A, Castaño S, García B, Martínez-Herrada B, Vinyes G, Lafuente A, Becker JT, Galán JJ, Serrano-Ríos M; Alzheimer's Disease Neuroimaging Initiative, Vázquez E, Tárraga L, Sáez ME, López OL, Real LM, Ruiz A.

Genome Med. 2011 May 31;3(5):33. doi: 10.1186/gm249.

37.

Estrogen receptor alpha gene variants are associated with Alzheimer's disease.

Boada M, Antunez C, López-Arrieta J, Caruz A, Moreno-Rey C, Ramírez-Lorca R, Morón FJ, Hernández I, Mauleón A, Rosende-Roca M, Martínez-Lage P, Marín J, Tárraga L, Alegret M, Pedrajas JR, Urda N, Royo JL, Saez ME, Gayán J, González-Pérez A, Real LM, Ruiz A, Galán JJ.

Neurobiol Aging. 2012 Jan;33(1):198.e15-24. doi: 10.1016/j.neurobiolaging.2010.06.016. Epub 2010 Jul 31.

PMID:
20674091
38.

Brain perfusion correlates of visuoperceptual deficits in mild cognitive impairment and mild Alzheimer's disease.

Alegret M, Vinyes-Junqué G, Boada M, Martínez-Lage P, Cuberas G, Espinosa A, Roca I, Hernández I, Valero S, Rosende-Roca M, Mauleón A, Becker And JT, Tárraga L.

J Alzheimers Dis. 2010;21(2):557-67. doi: 10.3233/JAD-2010-091069.

39.

Hospital's activity-based financing system and manager-physician [corrected] interaction.

Crainich D, Leleu H, Mauleon A.

Eur J Health Econ. 2011 Oct;12(5):417-27. doi: 10.1007/s10198-010-0255-1. Epub 2010 May 25. Erratum in: Eur J Health Econ. 2010 Dec;11(6):599.

PMID:
20499128
40.

GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers.

Ramirez-Lorca R, Boada M, Saez ME, Hernandez I, Mauleon A, Rosende-Roca M, Martinez-Lage P, Gutierrez M, Real LM, Lopez-Arrieta J, Gayan J, Antunez C, Gonzalez-Perez A, Tarraga L, Ruiz A.

J Nutr Health Aging. 2009 Mar;13(3):214-9.

PMID:
19262956
41.

Detection of visuoperceptual deficits in preclinical and mild Alzheimer's disease.

Alegret M, Boada-Rovira M, Vinyes-Junqué G, Valero S, Espinosa A, Hernández I, Modinos G, Rosende-Roca M, Mauleón A, Becker JT, Tárraga L.

J Clin Exp Neuropsychol. 2009 Oct;31(7):860-7. doi: 10.1080/13803390802595568. Epub 2009 Jan 14.

42.

The optimality of hospital financing system: the role of physician-manager interactions.

Crainich D, Leleu H, Mauleon A.

Int J Health Care Finance Econ. 2008 Dec;8(4):245-56. doi: 10.1007/s10754-008-9039-x. Epub 2008 Jun 22.

PMID:
18568434
43.

Patients experiencing local anaesthesia and hip surgery.

Mauleon AL, Palo-Bengtsson L, Ekman SL.

J Clin Nurs. 2007 May;16(5):892-9.

PMID:
17462039
44.

Anaesthesia care of older patients as experienced by nurse anaesthetists.

Mauleon AL, Palo-Bengtsson L, Ekman SL.

Nurs Ethics. 2005 May;12(3):263-72.

PMID:
15921343
45.
46.

[Hypertrophic pachymeningitis. A review of the histories of two cases and pathological relationship with the Tolosa-Hunt syndrome and the orbital pseudotumor].

Bosch J, Ortega-Aznar A, Tintoré M, Río J, Ferreira R, Rubio E, Rovira A, Abilleira S, Mauleón A, Montalbán X, Boada M, Codina A.

Rev Neurol. 2000 Nov 16-30;31(10):946-51. Spanish.

PMID:
11244689
47.

Mitral papillary fibroelastoma as a cause of cardiogenic embolic stroke: report of two cases and review of the literature.

Sastre-Garriga J, Molina C, Montaner J, Mauleón A, Pujadas F, Codina A, Alvarez-Sabín J.

Eur J Neurol. 2000 Jul;7(4):449-53. Review.

PMID:
10971607
48.

[Progressive multifocal leukoencephalopathy in elderly immunocompetent patients. Report of 2 cases].

Bosch J, Sumalla J, Mauleón A, Rovira A, Molins M, Acarín N.

Rev Neurol. 1999 Jul 16-31;29(2):133-7. Spanish.

PMID:
10528326
49.

[Intraventricular hemorrhage due to the rupture of atherosclerotic dissecting aneurysm of the middle cerebral artery].

Bosch J, Mauleón A, Coscojuela P, Porta I, Grivé E, Alvarez-Sabín J, Vilalta J, Molins M, Codina A.

Rev Neurol. 1999 May 16-31;28(10):973-5. Spanish.

PMID:
10416234
50.

[Stroke: a stranger among the people].

Montaner J, Mauleón A, Vidal C, Molina C, Alvarez-Sabín J.

Rev Neurol. 1998 Dec;27(160):943-7. Spanish.

PMID:
9951009

Supplemental Content

Loading ...
Support Center